The effects of JNJ-39393406 a positive allosteric nicotine modulator on mood and cognition in patients with unipolar depression: A double-blind, add-on, placebo-controlled trial
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The effects of JNJ-39393406 a positive allosteric nicotine modulator on mood and cognition in patients with unipolar depression: A double-blind, add-on, placebo-controlled trial
Authors
Keywords
Nicotine modulator, Affective disorder, Cognition, Depression
Journal
EUROPEAN NEUROPSYCHOPHARMACOLOGY
Volume 51, Issue -, Pages 33-42
Publisher
Elsevier BV
Online
2021-05-21
DOI
10.1016/j.euroneuro.2021.04.020
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dysregulation of Kynurenine Pathway and Potential Dynamic Changes of Kynurenine in Schizophrenia: A Systematic Review and Meta-Analysis
- (2021) Bing Cao et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- α7 nicotinic acetylcholine receptors as therapeutic targets in schizophrenia: Update on animal and clinical studies and strategies for the future
- (2020) Alvin V. Terry et al. NEUROPHARMACOLOGY
- Memantine treatment exerts an antidepressant-like effect by preventing hippocampal mitochondrial dysfunction and memory impairment via upregulation of CREB/BDNF signaling in the rat model of chronic unpredictable stress-induced depression
- (2020) Sandeep K. Mishra et al. NEUROCHEMISTRY INTERNATIONAL
- The role of memantine in the treatment of major depressive disorder: Clinical efficacy and mechanisms of action
- (2018) Meysam Amidfar et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Efficacy and Safety of the α7-Nicotinic Acetylcholine Receptor Agonist ABT-126 in the Treatment of Cognitive Impairment Associated With Schizophrenia
- (2018) George M. Haig et al. JOURNAL OF CLINICAL PSYCHIATRY
- GABA A receptor: Positive and negative allosteric modulators
- (2018) Richard W. Olsen NEUROPHARMACOLOGY
- Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States
- (2018) Deborah S. Hasin et al. JAMA Psychiatry
- Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia
- (2015) David Walling et al. SCHIZOPHRENIA BULLETIN
- Toward the identification of neurocognitive subtypes in euthymic patients with bipolar disorder
- (2014) Diego J. Martino et al. JOURNAL OF AFFECTIVE DISORDERS
- Neuropsychological deficits in bipolar depression persist after successful antidepressant treatment
- (2013) Sara Poletti et al. JOURNAL OF AFFECTIVE DISORDERS
- Treating Impaired Cognition in Schizophrenia
- (2012) H. M. Ibrahim et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents
- (2012) S Miyamoto et al. MOLECULAR PSYCHIATRY
- Allosteric alpha-7 nicotinic receptor modulation and P50 sensory gating in schizophrenia: A proof-of-mechanism study
- (2012) Georg Winterer et al. NEUROPHARMACOLOGY
- Nicotinic acetylcholine receptors: From basic science to therapeutics
- (2012) Raymond Hurst et al. PHARMACOLOGY & THERAPEUTICS
- Positive allosteric modulators as an approach to nicotinic acetylcholine receptor-targeted therapeutics: Advantages and limitations
- (2011) Dustin K. Williams et al. BIOCHEMICAL PHARMACOLOGY
- Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease
- (2011) Tanya L. Wallace et al. BIOCHEMICAL PHARMACOLOGY
- Hippocampal α7 nicotinic acetylcholine receptor levels in patients with schizophrenia, bipolar disorder, or major depressive disorder
- (2011) Morten S Thomsen et al. BIPOLAR DISORDERS
- Effects of nicotine on attention and inhibitory control in healthy nonsmokers.
- (2011) Nicholas D. Wignall et al. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY
- Combined α7 nicotinic acetylcholine receptor agonism and partial serotonin transporter inhibition produce antidepressant-like effects in the mouse forced swim and tail suspension tests: A comparison of SSR180711 and PNU-282987
- (2011) Jesper T. Andreasen et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- The Brief Negative Symptom Scale: Psychometric Properties
- (2010) Brian Kirkpatrick et al. SCHIZOPHRENIA BULLETIN
- Light up and see: Enhancement of the visual mismatch negativity (vMMN) by nicotine
- (2009) Derek J. Fisher et al. BRAIN RESEARCH
- Initial Phase 2 Trial of a Nicotinic Agonist in Schizophrenia
- (2008) Robert Freedman et al. AMERICAN JOURNAL OF PSYCHIATRY
- Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension tests
- (2008) JT Andreasen et al. JOURNAL OF PSYCHOPHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started